The 黑料网 Lung Cancer Screening Registry (LCSR) helps clinicians monitor and demonstrate the quality of CT lung cancer screenings in their practice through periodic feedback reports that include peer and registry benchmarks. Because screening is performed on an asymptomatic population, there is an added responsibility for the medical community to ensure that risks and benefits are adequately measured and monitored.
Contributing data to the LCSR not only helps clinicians improve their own quality of care, but also helps improve and refine lung cancer screening care for everyone at the national level.
Latest Developments
The registry continues to expand and evolve as new requirements and priorities are identified by the LCSR Committee and input from the larger lung cancer screening community including
- Receipt of a planning grant to develop a module for actionable incidental pulmonary nodules (IPNs). The grant’s aim is to support the development of diagnostic performance feedback for physicians participating in quality improvement registries such as the LCSR. The IPN module will gather data to facilitate appropriate and timely follow-up patient care. Ella Kazerooni, MD, MS, F黑料网, and Ben Wandtke, MD, MS, grant physician co-advisors, present the expanded vision for the IPN module in a Harnessing the Value of Clinical Registries blog.
- LCSR participants can use their data for performance improvement projects related to improving adherence to annual screening, ensuring appropriate radiation dose, and increasing smoking cessation rates. Materials are available to guide facility teams through a performance improvement process for which CME is available.
